NYSE · Healthcare · Medical Devices · United Kingdom
Smith & Nephew plc ADR is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Smith & Nephew plc ADR stock.
Overvalued: intrinsic value $24.04 per share, market price $29.70, margin of safety -23.5% (as of 2026-10-30).
Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $24.04; the price of $29.70 is 24% above that value, and 80% of that value comes from beyond year five.
Leak Score: 61/100 on 12 of 12 signals (Faint Leak).
All 142 Medical Devices stocks
22 more in this industry show a wider margin of safety.
SNN is overvalued (as of the 2026-10-30 close). Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $24.04; the price of $29.70 is 24% above that value, and 80% of that value comes from beyond year five.
$24.04 per share (as of the 2026-10-30 close), against a market price of $29.70. That is a margin of safety of -23.5%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
61 out of 100, which we rate "Faint Leak", on 12 of 12 value investing signals.